Skip to content

Mike Paulden

  • Senior Research Associate
  • University of Alberta
  • 17h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 1082CitationsNumber of citations received by Mike's publications. Updated daily.


I am an academic health economist, currently employed as a Senior Research Associate at the Faculty of Medicine and Dentistry at the University of Alberta. Until June 2013 I was a Research Associate at the Toronto Health Economics and Technology Assessment (THETA) Collaborative at the University of Toronto. My previous role was as a Research Fellow at the Team for Economic Evaluation and Health Technology Assessment at the Centre for Health Economics at the University of York. I hold a BA in Economics from the University of Cambridge and an MSc in Health Economics from the University of York. I was conferred an MA by the University of Cambridge in 2010. My research interests are in the economic evaluation of health technologies. I have worked on health technology assessments for the National Institute for Health Research and the National Institute for Health and Care Excellence (NICE) in the UK, and for Health Quality Ontario and the Ontario Ministry of Health and Long-Term Care in Canada. I have conducted economic analyses of a variety of health technologies and interventions, including screening programs for post-natal depression, neuromise inhibitors for the treatment of influenza, and gene expression profiling for targeting chemotherapy in early breast cancer. My research focuses upon a number of issues which carry implications for social decision making in health care, including the perspective on social choice adopted by decision makers, the cause and effect of growth in the cost-effectiveness threshold, and the social rate of time preference for health. This work has addressed a long-running dispute over the use of differential discounting in cost-effectiveness analysis and has challenged current practice in the UK and elsewhere. My current work focuses upon the legitimate role of social values in health resource allocation, and the appropriate means to incorporate these values into the methods used for the economic evaluation of health technologies.

Recent publications

  • Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial

    • Paulden M
    • McCabe C
  • Time Preference and Discounting

    • Paulden M

Professional experience

Senior Research Associate

University of Alberta

July 2013 - Present

Research Associate

University of Toronto

August 2009 - June 2013(4 years)

Research Fellow

University of York

October 2007 - July 2009(2 years)


MSc in Health Economics

University of York

October 2006 - September 2007(a year)

BA in Economics

University of Cambridge

October 2003 - June 2006(3 years)

Co-authors (196)

Other IDs